PARK7 and esophageal squamous cell carcinoma: In summary, although we did not find any value for DJ-1 regulatory pathways in predicting the prognosis of patients with ESCC, serum DJ-1 level could be a useful biomarker to predict survival in patients with ESCC receiving radiotherapy, which still needs to be validated using a large sample of clinical data.